Is ketamine therapy appropriate for Christians? FDA-approved esketamine (Spravato) is a legitimate treatment for treatment-resistant depression — but the dissociative experience, the proliferation of for-profit ketamine clinics, and the spiritual vulnerability question make this more complex than a simple yes or no.
Medical Disclaimer: GodlyScore is not a medical authority. Nothing here is medical advice. Consult a licensed physician. SAMHSA: 1-800-662-4357 (free, 24/7).
The question "Is ketamine appropriate for Christians?" contains two very different questions that require separate answers:
Question 1 — Clinical/supervised ketamine therapy: FDA-approved esketamine (Spravato) for treatment-resistant depression, administered in a certified healthcare setting under physician supervision. This is a legitimate medical treatment with clinical evidence.
Question 2 — Recreational ketamine: Using ketamine outside of supervised medical settings for its dissociative and euphoric effects — a Schedule III controlled substance used illegally as a club drug. This is a separate and clear concern.
This guide addresses both, but the primary focus is the clinical question because that is what Christians with severe depression are actually searching for.
In 2019, the FDA approved esketamine (brand name Spravato), a nasal spray form of ketamine's active enantiomer, for treatment-resistant depression (TRD) in adults — defined as depression that has not responded to at least two adequate antidepressant trials. The approval was based on clinical trials showing rapid antidepressant effects (often within hours to days) compared to weeks for traditional antidepressants. Spravato is administered in a certified healthcare setting where the patient is monitored for at least two hours after each dose due to the dissociative effects.
This is a real FDA approval based on real clinical evidence for a genuine, severe medical condition. The FDA has also approved esketamine for major depressive disorder with suicidal ideation or behavior. For Christians experiencing treatment-resistant depression — a condition that causes immense suffering and significant risk — the existence of a legitimate, monitored, physician-supervised treatment option is relevant information. Luke the physician is commended (Colossians 4:14); medicine for genuine suffering is not sinful.
Ketamine produces dissociative effects — a sense of detachment from the body and environment, altered perception of self and surroundings, and in higher doses, "k-hole" experiences of complete disconnection from reality. Many ketamine therapy patients describe these experiences as profoundly spiritual — encounters with a divine presence, out-of-body experiences, feelings of cosmic unity. Some ketamine clinics explicitly market these spiritual experiences as part of the treatment's value.
This is the specific concern for Christians: the same dynamic raised with psilocybin applies here. Chemically induced spiritual experiences — whatever their content — occur outside prayer, Scripture, community, and the means God has ordained for genuine spiritual encounter. 1 John 4:1 — "test the spirits to see whether they are from God" — applies to experiences that feel profoundly spiritual but are produced by a dissociative anesthetic. The Holy Spirit does not require chemical induction.
For supervised clinical use: The FDA-approved protocol minimizes dissociative experience through controlled dosing and medical setting. Spravato is not a "trip" in the recreational sense — it is a medically administered dose under supervision with safety monitoring. The spiritual experience concern applies more to recreational use and to for-profit "experiential ketamine" clinics that market the dissociative experience as the therapeutic mechanism.
The success of FDA-approved ketamine has spawned a wave of for-profit ketamine infusion clinics operating outside the FDA Spravato protocol — offering IV ketamine infusions at $400-800 per session, often without robust psychiatric oversight, and marketing the "transformative experience" rather than the medical outcome. The FDA has issued warning letters to clinics making unapproved claims. Proverbs 11:14 applies: when the guidance patients receive is shaped by $500-per-session financial interest rather than patient welfare, discernment is required.
See our guide on Are SSRIs Appropriate for Christians? for the standard antidepressant framework. See our Drug & Pharmaceutical Discernment hub. FDA guidance on ketamine products. SAMHSA provides mental health treatment resources.
Rate any movie, show, song, or channel for spiritual alignment.
Visit GodlyScore.com →